Fermont Irene R, Livneh Ayalah, Benhamou Michel
ERANIM Israel Task Force Jerusalem, Israel.
Ther Adv Drug Saf. 2022 Aug 5;13:20420986221112189. doi: 10.1177/20420986221112189. eCollection 2022.
The scientific communication landscape has undergone a significant disruption since the COVID-19 pandemic: a huge number of publications, ample use of preprint publications, a fast-spreading digitalized information. This reflected the unprecedented speed of the research on disease and vaccines. Two kinds of infodemic blew up very soon: a scientific and a tabloid one. With knowledge evolving continuously, governments and institutions deployed their communication campaigns very quickly to explain the different measures, including the vaccination strategies and to fight against infodemics. The need for a more focused population, the French-speaking community, arose spontaneously in Israel, leading to the creation of a Vaccine Task Force, independent, multidisciplinary, and composed of 20 high-level volunteers, physicians, pharmacists, and scientists, which provides evidence-based information, open and free, to healthcare professionals and the public, both most in demand, and then the experts' meetings in Israel and abroad. Current resources: 40 webinars, all recorded and accessible on the association website, questions and answers, press and scientific literature review, and hotline; communication through the website, social media, and audio-visual media. In French, English, and Hebrew. The team undertook to explain the role of Israel in vaccine rollout and real-world data provision to the international community, both in Israel and abroad. Performance indicators are as follow: attendees' number (~3000), website frequentation (7200 +) social media followers. In conclusion, this information campaign requires no budget; relies on volunteers who expressed their willingness to contribute to the global effort, as seen all over the world; and uses simple, cheap, and ubiquitous IT platforms. The Task Force created ERANIM, the Israel Society for Medication and Vaccines Safety. This scheme could easily apply for minorities or for medium/low-income countries, using the resources available in WHO, Vaccine Safety Net, health agencies, and academies. Key factors are multidisciplinary, influencers belonging to communities, and a network of partnerships.
The scientific communication landscape has undergone a significant disruption since the COVID-19 pandemic: a huge number of publications, ample use of preprint publications, a fast-spreading digitalized information. This reflected the unprecedented speed of the research on disease and vaccines. Two kinds of infodemic blew up very soon: a scientific and a tabloid one. With knowledge evolving continuously, governments and institutions deployed their communication campaigns very quickly to explain the different measures, including the vaccination strategies and to fight against infodemics. The need for a more focused population, the French-speaking community, arose spontaneously in Israel, leading to the creation of a Vaccine Task Force, independent, multidisciplinary, and composed of 20 high-level volunteers, physicians, pharmacists, and scientists, which provides science-based information, open and free, to healthcare professionals and the public, both most in demand, and then the experts' meetings in Israel and abroad. Current resources: More than 40 webinars, recorded, questions and answers, press and scientific literature review, and hotline, through the website, social media, and audio-visual media. In French, English, and Hebrew. The team undertook to explain the role of Israel in vaccine rollout and real-world data provision to the international community, both in Israel and abroad. Performance indicators are as follow: attendees number (~3000), website frequentation (7200 +) social media followers. This information campaign requires no budget; relies on volunteers who expressed their willingness to contribute to the global effort, as seen all over the world; and uses simple, cheap, and ubiquitous IT platforms. The Task Force created ERANIM, the Israel Society for Medication and Vaccines Safety. This scheme could easily apply for minorities or for medium/low-income countries, using the resources available in WHO, Vaccine Safety Net, health agencies, and academies. Key factors are multidisciplinary, influencers belonging to communities, and a network of partnerships.
自新冠疫情以来，科学传播格局发生了重大变革：出版物数量庞大，预印本出版物大量使用，数字化信息迅速传播。这反映了疾病和疫苗研究的空前速度。很快爆发了两种信息疫情：一种是科学方面的，一种是小报式的。随着知识不断更新，政府和机构迅速开展宣传活动，解释包括疫苗接种策略在内的各种措施，并抗击信息疫情。以色列自发出现了针对更特定人群即法语社区的需求，从而成立了疫苗特别工作组，该工作组独立、多学科，由20名高级志愿者、医生、药剂师和科学家组成，为最有需求的医疗专业人员和公众提供基于证据的、开放且免费的信息，随后还举办了以色列国内外的专家会议。现有资源包括：40场网络研讨会，全部录制并可在协会网站上获取，还有问答、新闻和科学文献综述以及热线；通过网站、社交媒体和视听媒体进行传播。提供法语、英语和希伯来语版本。该团队致力于向以色列国内外的国际社会解释以色列在疫苗推广和提供真实世界数据方面所发挥的作用。绩效指标如下：参会人数（约3000人）、网站访问量（7200次以上）、社交媒体关注者数量。总之，这场宣传活动无需预算；依靠那些表示愿意为全球努力做出贡献的志愿者，这在世界各地都能看到；并且使用简单、廉价且普遍存在的信息技术平台。特别工作组创建了ERANIM，即以色列药物和疫苗安全协会。该方案可以很容易地应用于少数群体或中低收入国家，利用世界卫生组织、疫苗安全网、卫生机构和学术机构现有的资源。关键因素包括多学科性、属于社区的有影响力人士以及伙伴关系网络。
自新冠疫情以来，科学传播格局发生了重大变革：出版物数量庞大，预印本出版物大量使用，数字化信息迅速传播。这反映了疾病和疫苗研究的空前速度。很快爆发了两种信息疫情：一种是科学方面的，一种是小报式的。随着知识不断更新，政府和机构迅速开展宣传活动，解释包括疫苗接种策略在内的各种措施，并抗击信息疫情。以色列自发出现了针对更特定人群即法语社区的需求，从而成立了疫苗特别工作组，该工作组独立、多学科，由20名高级志愿者、医生、药剂师和科学家组成，为最有需求的医疗专业人员和公众提供基于科学的、开放且免费的信息，随后还举办了以色列国内外的专家会议。现有资源包括：40多场录制的网络研讨会、问答、新闻和科学文献综述以及热线，通过网站、社交媒体和视听媒体提供。提供法语、英语和希伯来语版本。该团队致力于向以色列国内外的国际社会解释以色列在疫苗推广和提供真实世界数据方面所发挥的作用。绩效指标如下：参会人数（约3000人）、网站访问量（7200次以上）、社交媒体关注者数量。这场宣传活动无需预算；依靠那些表示愿意为全球努力做出贡献的志愿者，这在世界各地都能看到；并且使用简单、廉价且普遍存在的信息技术平台。特别工作组创建了ERANIM，即以色列药物和疫苗安全协会。该方案可以很容易地应用于少数群体或中低收入国家，利用世界卫生组织、疫苗安全网、卫生机构和学术机构现有的资源。关键因素包括多学科性、属于社区的有影响力人士以及伙伴关系网络。
